In Response to The Challenges of Pharmacotherapy of SARS-CoV-2 Infection in Patients with Sudden Sensorineural Hearing Loss Due to COVID-19

Laryngoscope. 2021 Jul;131(7):E2336. doi: 10.1002/lary.29517. Epub 2021 Mar 17.

Authors

Christine Little¹, Maura K Cosetti^{1

2}

Affiliations

¹ Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, U.S.A.
² Ear Institute, New York Eye and Ear Infirmary of Mount Sinai, New York, U.S.A.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Hearing Loss, Sensorineural* / drug therapy
Hearing Loss, Sensorineural* / etiology
Hearing Loss, Sudden* / drug therapy
Hearing Loss, Sudden* / etiology
Humans
Ototoxicity*
SARS-CoV-2